血栓管理設備市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

推動血栓管理設備增長的關鍵因素包括心血管疾病的增加、人口老齡化以及意識的提高導致血栓管理設備的使用增加。

根據世界衛生組織 (WHO) 的數據，心血管疾病每年在全球造成 1790 萬人死亡。 此外，中風和心髒病發作的患病率增加以及對治療血栓的微創手術的需求不斷增長預計將推動市場增長。

此外，血栓管理技術的進步以及公司為創新血栓管理治療方法所做的努力進一步推動了市場的增長。 然而，嚴格的監管政策和替代療法的可用性預計會阻礙市場增長。

血栓管理設備的市場趨勢

神經血管栓塞有望顯著增長

• 由於研發投資的增加和產品技術的持續創新，神經血管栓塞有望實現顯著增長。
• 此外，對微創手術的需求不斷增加以及患者對這些治療的認識不斷提高預計將推動該細分市場的增長。
• 根據世界衛生組織 (WHO) 的數據，患有深靜脈血栓形成 (DVT) 和肺栓塞 (PE) 的人數遠遠超過患有艾滋病和癌症的人數。 2015 年，美國約有 900 萬人被診斷出患有 DVT 和 PE。
• 此外，髖關節、膝關節和脊柱手術（這些都是中風的高危因素）的增加預計將推動中風相關導管引導溶栓市場的發展。 此外，久坐不動的生活方式和不健康的飲食導致肥胖和其他靜脈相關疾病也有望在預測期內推動市場增長。

預計北美將佔據較大的市場份額

由於有利的報銷政策和完善的醫療保健基礎設施的可用性，預計在預測期內北美將獲得很大的市場份額。 此外，心髒病患者的負擔和具有更好臨床結果的設備的技術進步正在推動美國的市場增長。 根據美國疾病控制與預防中心 (CDC) 的數據，截至 2019 年，美國估計有 795,000 人中風。 其中，610,000 人患有首次中風或新中風。 此外，僅在美國，中風每年就花費 340 億美元。

由於醫療保健基礎設施的改善、城市化帶來的久坐不動的生活方式以及該地區中風負擔增加等因素，預計亞太地區在預測期內將呈現顯著的增長率。 此外，更高的患者數量預計會增加醫療支出，預計這將推動預測期內的增長。

血栓管理器械市場競爭分析

血栓管理設備的全球市場適度整合且競爭激烈。 市場參與者正專注於產品創新、新產品發布和區域擴張，以增加市場份額。 在血栓管理設備市場運營的主要市場參與者包括美敦力公司、波士頓科學公司、Edward Lifesciences、AngioDynamics, Inc、LeMaitre Vascular, Inc。

其他好處

• Excel 格式的市場預測 (ME) 表
• 三個月的分析師支持

內容

第一章介紹

• 調查結果
• 調查假設
• 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

• 市場概覽
• 市場驅動因素
  • 心血管疾病患病率和人口老齡化
  • 對微創手術和技術進步的需求不斷增加
• 市場製約因素
  • 嚴格的監管程序
  • 替代療法的可用性
• 波特的五力分析
  • 新進入者的威脅
  • 買方/消費者議價能力
  • 供應商的議價能力
  • 替代品的威脅
  • 競爭公司之間的敵對關係

第 5 章市場細分

• 按產品分類
  • 取栓導管
  • 導管引導溶栓裝置
  • 經皮取栓裝置
  • 下腔靜脈濾器
  • 神經血管栓塞裝置
• 最終用戶
  • 醫院
  • 門診手術中心
  • 其他
• 按地區
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 中東和非洲
    • 海灣合作委員會
    • 南非
    • 其他中東和非洲地區
  • 南美洲地區
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章競爭格局

• 公司簡介
  • Medtronic Plc
  • Boston Scientific Corporation
  • Edward Lifesciences
  • Teleflex Incorporated
  • Johnson & Johnson
  • LeMaitre Vascular, Inc.
  • Strub Medical GmbH & Co. KG
  • AngioDynamics
  • iVascular SLU
  • Cook Group Incorporated

第7章 市場機會今後動向

The key driving factors for the growth of clot management devices include increasing prevalence of cardiovascular diseases, rise in geriatric population and growing awareness which is leading to increased use of clot management devices. According to the World Health Organization (WHO), cardiovascular diseases cause 17.9 million deaths each year worldwide. Furthermore, increasing prevalence of stroke and heart attack, growing demand for minimally invasive procedures in the treatment of blood clots is expected to bolster the market growth.

In addition, advances in clot management technologies and efforts of the companies in innovating the treatments for blood clot management are further fuelling the market growth. However, stringent regulatory policies and availability of alternative treatments are expected to hamper the market growth.

Clot Management Devices Market Trends

Neurovascular Embolectomy is Expected to Register Significant Growth

• Neurovascular embolectomy projected to have significant growth rate owing to increasing R&D investments and continuous innovations in product technologies.
• Furthermore, growing demand for minimally invasive procedures coupled with rising awareness in patients regarding these treatments is expected to fuel the segment growth.
• According to the World Health Organization (WHO), the number of people suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE) is much larger than people suffering from AIDS, and Cancer. During the year 2015, around 9,00,000 people were diagnosed by DVT & PE in United States.
• Furthermore, rise in hip, knee and spinal surgeries which are high-risk factors for stroke are expected to boost the stroke-related catheter-directed thrombolysis market. Moreover, sedentary lifestyle and unhealthy food habits leading to obesity and other vein related diseases expected to boost the market growth over the forecast period.

North America is Expected to have Significant Market Share

North America is projected to have significant market share over the forecast period owing to favourable reimbursement policies and availability of well-established healthcare infrastructure. In addition, the burden of cardiac patients and technological advancements in devices to produce better clinical outcomes are driving the market growth in United States. According to the Center for Disease Control (CDC), approximately, 795,000 people in the United Sstates are having stroke as of 2019. Of these, 610,000 are first or new strokes. Furthermore, stroke annually costs 34 billion in United States alone.

The Asia Pacific region is projected to have notable growth rate over the forecast period owing to the factors such as improving healthcare infrastructure, urbanization leading to the sedentary lifestyle and growing burden of stroke in the region. Moreover, a large patient pool growing healthcare spending in the region expected to bolster the regional growth over the forecast period.

Clot Management Devices Market Competitive Analysis

Global clot management devices market is moderately consolidated and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. The key market players operating in clot management devices market include Medtronic Plc, Boston Scientific Corporation, Edward Lifesciences, AngioDynamics, Inc. and LeMaitre Vascular, Inc. among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Prevalence of Cardiovascular Diseases and Ageing Population
  • 4.2.2 Growing Demand for Minimally Invasive Surgeries and Advancements in Technologies
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulatory Procedures
  • 4.3.2 Availability of Alternative Treatments
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Product
  • 5.1.1 Embolectomy Balloon Catheter
  • 5.1.2 Catheter Directed Thrombolysis Devices
  • 5.1.3 Percutaneous Thrombectomy Devices
  • 5.1.4 Inferior Vena cava Filters
  • 5.1.5 Neurovascular Embolectomy Devices
• 5.2 By End-User
  • 5.2.1 Hospitals
  • 5.2.2 Ambulatory Surgical Centers
  • 5.2.3 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Medtronic Plc
  • 6.1.2 Boston Scientific Corporation
  • 6.1.3 Edward Lifesciences
  • 6.1.4 Teleflex Incorporated
  • 6.1.5 Johnson & Johnson
  • 6.1.6 LeMaitre Vascular, Inc.
  • 6.1.7 Strub Medical GmbH & Co. KG
  • 6.1.8 AngioDynamics
  • 6.1.9 iVascular SLU
  • 6.1.10 Cook Group Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS